| P50 | author | Sharon Gorski | Q54956626 |
| | Marcel B Bally | Q59187131 |
| P2093 | author name string | Hugo M Horlings | |
| | Nancy E Go | |
| | Andrew I Minchinton | |
| | Karen A Gelmon | |
| | Wieslawa H Dragowska | |
| | Samuel Leung | |
| | Svetlana Bortnik | |
| | Jennifer H Baker | |
| | Chandra Lebovitz | |
| | Courtney Choutka | |
| P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Q22676705 |
| | HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates | Q24296107 |
| | Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene | Q24617547 |
| | Comprehensive molecular portraits of human breast tumours | Q24630844 |
| | Autophagy in cancer | Q26999216 |
| | Autophagy in malignant transformation and cancer progression | Q27000191 |
| | Emerging strategies to effectively target autophagy in cancer | Q27009194 |
| | Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab | Q27346475 |
| | Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion | Q27933991 |
| | A ubiquitin-like system mediates protein lipidation | Q27934137 |
| | Dual roles of Atg8-PE deconjugation by Atg4 in autophagy. | Q27937267 |
| | Induction of autophagy and inhibition of tumorigenesis by beclin 1 | Q28131718 |
| | The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 |
| | Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype | Q28271274 |
| | LC3 conjugation system in mammalian autophagy | Q28278334 |
| | Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 |
| | Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3 | Q29614176 |
| | Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy | Q30646716 |
| | Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain | Q33283845 |
| | High-throughput fluorescence assay for small-molecule inhibitors of autophagins/Atg4. | Q33796350 |
| | ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss | Q33878879 |
| | Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations | Q34017017 |
| | Autophagy is required for glucose homeostasis and lung tumor maintenance | Q34017543 |
| | Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy. | Q34022661 |
| | The importance of autophagy regulation in breast cancer development and treatment. | Q34275855 |
| | ATG4B promotes colorectal cancer growth independent of autophagic flux. | Q34373013 |
| | Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates | Q34606285 |
| | Immune effects of trastuzumab | Q35057976 |
| | Identifying Small Molecules which Inhibit Autophagy: a Phenotypic Screen Using Image-Based High-Content Cell Analysis | Q35111620 |
| | Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. | Q35223716 |
| | Targeted therapy in her2-positive metastatic breast cancer: a review of the literature | Q35239603 |
| | The functional and pathologic relevance of autophagy proteases | Q35242420 |
| | Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. | Q35676481 |
| | Autophagy: friend or foe in breast cancer development, progression, and treatment | Q35684456 |
| | Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. | Q35846880 |
| | A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors | Q35852826 |
| | Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity | Q35853244 |
| | Resistance to Trastuzumab in Breast Cancer. | Q36318226 |
| | Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment | Q36926125 |
| | Autophagy in breast cancer and its implications for therapy | Q36966812 |
| | Interaction between Her2 and Beclin-1 proteins underlies a new mechanism of reciprocal regulation | Q37012420 |
| | Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis | Q37019194 |
| | The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer | Q37111104 |
| | AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation | Q37158353 |
| | Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer | Q37198196 |
| | Autophagy regulation by nutrient signaling | Q37429067 |
| | Herceptin resistance database for understanding mechanism of resistance in breast cancer patients. | Q37666730 |
| | Making new contacts: the mTOR network in metabolism and signalling crosstalk | Q38189969 |
| | Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy | Q38709994 |
| | SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells | Q38812006 |
| | Development of fluorescent substrates and assays for the key autophagy-related cysteine protease enzyme, ATG4B. | Q38882927 |
| | Identification of secreted proteins that reflect autophagy dynamics within tumor cells | Q38931162 |
| | Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy | Q39067690 |
| | The Beclin 1 interactome | Q40011745 |
| | A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity. | Q40343998 |
| | Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer. | Q42457245 |
| | The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells. | Q42457841 |
| | Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu | Q42807740 |
| | Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers | Q45121992 |
| | Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3 | Q56777123 |
| | Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification | Q58813303 |
| | Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts | Q80996595 |
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 66970-66988 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Identification of breast cancer cell subtypes sensitive to ATG4B inhibition | |
| P478 | volume | 7 | |